4559:TYO
Zeria Pharmaceutical Co Ltd
၁,၉၂၅.၀၀ JP¥
arrow_downward
-၀.၂၁%(-၄.၀၀) 1D
အောက် ၉, GMT+၉ ၁၅:၃၀:၀၀ · JPY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4559...
Open
၁,၉၂၃ JP¥
High
၁,၉၄၀ JP¥
Low
၁,၉၁၉ JP¥
Mkt. cap
ဋေ ၉.၆၅ ထ
Avg. vol.
၁.၇၀ သိန်း
Volume
၇.၇၅ သောင်း
Dividend
၂.၅၅%
Quarterly dividend
၁၂ JP¥
Ex-dividend date
၂၀၂၆ စက် ၂၉
P/E ratio
၁၀.၃၁
52-wk high
၂,၄၃၄ JP¥
52-wk low
၁,၈၇၈ JP¥
EPS
၁၈၇ JP¥
Shares outstanding
၅.၀၁ ကုဋေ
No. of employees
၂ ထောင်
Open
၁,၉၂၃ JP¥
High
၁,၉၄၀ JP¥
Low
၁,၉၁၉ JP¥
Mkt. cap
ဋေ ၉.၆၅ ထ
Avg. vol.
၁.၇၀ သိန်း
Volume
၇.၇၅ သောင်း
Dividend
၂.၅၅%
Quarterly dividend
၁၂ JP¥
Ex-dividend date
၂၀၂၆ စက် ၂၉
P/E ratio
၁၀.၃၁
52-wk high
၂,၄၃၄ JP¥
52-wk low
၁,၈၇၈ JP¥
EPS
၁၈၇ JP¥
Shares outstanding
၅.၀၁ ကုဋေ
No. of employees
၂ ထောင်
News stories
From web sources and news partners
Seeking Alpha
·
ပြီးခဲ့သည့် ၃၅ မိနစ်
S&P 500: The Quick And Easy Days Are Over (SP500)
The Globe and Mail
·
ပြီးခဲ့သည့် ၁ နာရီ
Beyond S&P 500 Index Funds: Here's the 1 Sector I'd Buy First as a New Investor
AskTraders.com
·
ပြီးခဲ့သည့် ၅၈ မိနစ်
S&P 500: Why UBS Says Investors Should ‘Stay Invested Near Record Highs’
Yahoo Finance
·
ပြီးခဲ့သည့် ၃ နာရီ
The S&P 500 Just Hit a Record High -- Here's How Much Higher It Can Climb, According to the Wall Street Consensus
Profile
Zeria Shinyaku Kōgyō KK is a Japanese drug manufacturer that obtained Tillotts Pharma AG.
In 1955, the Japanese Kisaku Ibu, former Yamanouchi Seiyaku executive opened a new pharmaceutical company in Tokyo under the name Zeria Yakushō Kenkyusho. In 1970, this company becomes Zeria Shinyaku Zeria Shinyaku KK.
In 1975, it built a new factory in Kumagaya in Saitama prefecture, before the main factory in Tsukuba which was constructed by Takenaka Corporation in 1988.
In 2009, the company obtained Switzerland company Tillotts Pharma AG, and began operating internationally through a large network of subsidiaries,
It manufactures and sells pharmaceuticals in Sweden, Ireland, UK, Czech Republic, Spain, Germany, France, Italy, Vietnam and Denmark. The drug itself is developed in Switzerland, Tillotts Parma.
The company owns a 6.63% share of Asuka Seiyaku, also a pharmaceutical company, other than its subsidiaries.
The main shareholder of the company is the company itself, the present president Mitsuhiro Ibu, Mitsubishi UFJ Financial Group, Custody Bank of Japan, Morinaga Milk Industry, SMBC, Mizuho Bank, Risona Bank, Aioi Nissay Dowa Insurance as of March 2023. Wikipedia
About Zeria Pharmaceutical Co Ltd